Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties.

Zhou Z, Guo J, Hetrick B, Tiwari S, Haikerwal A, Han Y, Bond VC, Huang MB, Mankowski MK, Snyder BA, Hogan PA, Sharma SK, Liotta DC, Reid TE, Wilson LJ, Wu Y. Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties. PLoS Pathog. 2024 Aug; 20(8):e1012448.

View in: PubMed

subject areas

Anti-HIV Agents
CD4-Positive T-Lymphocytes
HIV Fusion Inhibitors
HIV Infections
HIV-1
Humans
Receptors, CXCR4
Triazoles
Virus Internalization

authors with profiles

Vincent Bond

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support